Corporate Profile: Camber Pharmaceuticals, Inc

Pharmacy Times, August 2021, Volume 87, Issue 8
Pages: 46

CAMBER IS COMMITTED TO CONTINUOUS SUPPLY IN GENERICS

The past 18 months have been the most challenging in memory, and Camber has done everything possible to provide uninterrupted access to all our essential medicines. In the face of numerous challenges, our parent company, Hetero Drugs of India, has worked tirelessly to maintain the integrity of our supply chain while also leading the fight against COVID-19 worldwide.

Hetero was the first company to launch the licensed generic version of remdesivir in the Indian pharmaceutical market under the brand name CoviforTM. Hetero is producing over 100 million doses of the Sputnik V COVID-19 vaccine per year in India; it is the world’s first registered vaccine against the novel coronavirus infection. Hetero is continually adding to its manufacturing capabilities, including its own KSMs (key starting material), and has more than doubled tech transfers between facilities to ensure continued production of both APIs (active pharmaceutical ingredient) and finished doses.

VERTICALLY INTEGRATED GLOBAL RESOURCES

We have achieved many of the goals we set for ourselves at the beginning of 2021 in impressive fashion. Among them are building and maintaining an abundant inventory of safety stock on many items that our customers depend on most. We have also completed our new headquarters and warehouse facility, greatly expanding our capabilities. We utilize our global resources to bring value as a trusted and reliable trading partner.

EXPANDING AND DIVERSIFYING OUR PORTFOLIO

Long known for being leaders in antiviral and antiretroviral products, Hetero and Camber will soon be launching a comprehensive portfolio of oncology products. Having recently launched several injectable products, Camber has added a variety of dose forms to our product line, including suppositories, ointments, and suspensions.

CAMBER CONSUMER CARE, OUR OTC DIVISION

Camber Consumer Care has recently introduced several new products to our growing portfolio of allergy, pain, and gastroenterology products, including loratadine, omeprazole, and polyethylene glycol. Our mission is to provide a focused and reliable supply of over-the-counter drugs to the marketplace, creating value for our partners and savings for the consumer. Our vision is to become a strategic supplier to retailers demanding a quality-driven, reliable, and responsive OTC store brand source.

Camber goes the extra mile to understand the dynamics and concerns facing our customers. From sales to finance, from customer service to supply chain, the people of Camber foster high-touch relationships across all departments of your organization. Camber is committed to customer service and continuous supply. We value your partnership.